Table 5.
Mean percent change from baseline urinary 3-OH-B[a]P levels adjusted for creatinine (fg/mgcreat) in smokers, switchers to THS, and abstainers in PMI’s clinical studies (per protocol populations).
| Study | Day 5 |
Day 90 |
||||
|---|---|---|---|---|---|---|
| THS | CC | SA | THS | CC | SA | |
| % change (95 % CI) | % change (95 % CI) | % change (95 % CI) | % change (95 % CI) | % change (95 % CI) | % change (95 % CI) | |
| 5-day Poland (30) | −71.43 (-76.65, -66.21) | −8.92 (-17.00, -0.84) | −77.24 (-81.14, -73.34) | NA | NA | NA |
| 5-day Japan (29) | −64.76 (-72.17, -57.35) | −2.75 (-13.51, 8.02) | −71.15 (-78.84, -63.46) | NA | NA | NA |
| 90-day Japan (31) | −68.42 (-74.27, -62.56) | −3.79 (-13.70, 6.11) | −67.04 (-76.32, -57.76) | −49.2 (-62.68, -35.71) | 21.49 (-1.00, 43.99) | −46.51 (-61.64, -31.37) |
| 90-day U.S. (32) | −68.31 (-74.94, -61.67) | −8.68 (-18.44, 1.08) | −75.41 (-83.48, -67.34) | −50.86 (-62.25, -39.47) | 18.37 (-13.68, 50.41) | −41.82 (-63.36, -20.29) |